Microbiological Analysis and Mortality Risk Factors in Patients with Polymicrobial Bloodstream Infections

Junhong Xu1, Youhua Yuan1, Baoya Wang1

  • 1Department of Clinical Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, and People's Hospital of Henan University, Zhengzhou, Henan, 450003, People's Republic of China.

PubMed
Abstract

Insights

Polymicrobial bloodstream infections are common in critically ill patients, often involving multidrug-resistant bacteria. ICU admission, shock, and central nervous system diseases are key mortality risk factors, necessitating careful antibiotic selection and reduced invasive procedures.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Critical Care Medicine

Background:

  • Polymicrobial bloodstream infections (PBSI) pose significant challenges in clinical settings.
  • Identifying etiological characteristics and prognostic risk factors is crucial for patient management.

Purpose of the Study:

  • To investigate the causes and risk factors influencing the outcomes of patients with PBSI.
  • To identify independent risk factors for mortality in PBSI patients.

Main Methods:

  • A retrospective study of 141 PBSI patients admitted to Henan Provincial People's Hospital in 2021.
  • Data collected included laboratory indexes, admission department, demographics, ICU stay, and procedures.
  • Univariate and multivariable analyses were used to determine mortality risk factors.

Main Results:

  • Coagulase-negative staphylococci and Klebsiella pneumoniae were the most frequent gram-positive and gram-negative bacteria, respectively.
  • High incidence of methicillin-resistant coagulase-negative staphylococci (75%) and carbapenem-resistant K. pneumoniae (45.7%) was observed.
  • Independent mortality risk factors identified include ICU admission, shock, electrolyte disorders, and central nervous system diseases. Patients with carbapenem-resistant PBSI had lower survival rates.

Conclusions:

  • Patients with PBSI are often critically ill and infected with multidrug-resistant organisms.
  • Monitoring infectious flora, judicious antibiotic use, and minimizing invasive procedures are vital to reduce mortality.